Medicare Enrolled
Dr. Leena Bondili, MD
Student in an Organized Health Care Education/Training Program · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bondili from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bondili?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bondili
Dr. Leena Bondili is a student in an organized health care education/training program specialist in Edison, NJ, with 8 years of NPI registration. Based on federal Medicare data, Dr. Bondili performed 5,084 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bondili received a total of $6,709 from 62 pharmaceutical and/or device companies across 338 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bondili is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 8 years of NPI registration
▲ Top 4% volume in NJ
$6,709 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,084
Medicare services
Top 4% in NJ for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,820 | $6 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
301 | $8 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $98 | $399 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
183 | $12 | $42 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
151 | $8 | $8 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
78 | $14 | $37 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
55 | $121 | $320 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
50 | $100 | $269 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
47 | $16 | $91 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $157 | $464 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $40 | $174 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $64 | $266 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $38 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $103 | $554 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $71 | $203 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $148 | $383 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.1% high complexity
80.3% medium
18.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,709
Total received (2020-2024)
Avg $1,342/year across 5 years
Top 5% in NJ for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
338
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,987
2023
$2,197
2022
$975
2021
$340
2020
$210
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,151
PFIZER INC.
$187
AstraZeneca Pharmaceuticals LP
$105
Merck Sharp & Dohme LLC
$102
BeiGene USA, Inc.
$94
ABBVIE INC.
$87
Eisai Inc.
$83
Celgene Corporation
$81
Regeneron Healthcare Solutions, Inc.
$81
Daiichi Sankyo Inc.
$77
Janssen Biotech, Inc.
$68
E.R. Squibb & Sons, L.L.C.
$65
Bayer Healthcare Pharmaceuticals Inc.
$56
Aveo Pharmaceuticals, Inc.
$55
Mirati Therapeutics, Inc.
$53
SpringWorks Therapeutics, Inc.
$50
Genmab U.S., Inc.
$50
Gilead Sciences, Inc.
$46
Apellis Pharmaceuticals, Inc.
$38
Takeda Pharmaceuticals U.S.A., Inc.
$36
Cumberland Pharmaceuticals, Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$34
Kyowa Kirin, Inc.
$33
SERVIER PHARMACEUTICALS LLC
$33
Azurity Pharmaceuticals, Inc.
$32
Genentech USA, Inc.
$32
Incyte Corporation
$30
Rigel Pharmaceuticals, Inc.
$28
Tempus AI, Inc
$20
Coherus Biosciences Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
TAIHO ONCOLOGY, INC.
$18
PharmaEssentia USA Corporation
$16
Lilly USA, LLC
$15
Blueprint Medicines Corporation
$15
ARRAY BIOPHARMA INC
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Top 3 companies account for 48.3% of 2024 payments
All-time payments by company (2020-2024) ›
Novartis Pharmaceuticals Corporation
$1,255
Amgen Inc.
$497
Merck Sharp & Dohme LLC
$333
E.R. Squibb & Sons, L.L.C.
$329
PFIZER INC.
$293
Gilead Sciences, Inc.
$279
Incyte Corporation
$235
Eisai Inc.
$217
Celgene Corporation
$209
Daiichi Sankyo Inc.
$201
BeiGene USA, Inc.
$182
Foundation Medicine, Inc.
$169
AVEO Pharmaceuticals, Inc.
$162
AstraZeneca Pharmaceuticals LP
$151
Bayer Healthcare Pharmaceuticals Inc.
$129
Alexion Pharmaceuticals, Inc.
$113
Regeneron Healthcare Solutions, Inc.
$106
Genentech USA, Inc.
$101
NOVARTIS PHARMACEUTICALS CORPORATION
$100
Rigel Pharmaceuticals, Inc.
$90
ABBVIE INC.
$87
Janssen Biotech, Inc.
$85
Mirati Therapeutics, Inc.
$82
Seagen Inc.
$70
SERVIER PHARMACEUTICALS LLC
$70
Exelixis Inc.
$69
ARRAY BIOPHARMA INC
$67
GENZYME CORPORATION
$63
Aveo Pharmaceuticals, Inc.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
SpringWorks Therapeutics, Inc.
$50
Genmab U.S., Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$48
Puma Biotechnology, Inc.
$47
Pharmacyclics LLC, An AbbVie Company
$45
Apellis Pharmaceuticals, Inc.
$38
TAIHO ONCOLOGY, INC.
$37
Pharmacosmos Therapeutics Inc.
$36
Astellas Pharma US Inc
$34
Cumberland Pharmaceuticals, Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$34
Kyowa Kirin, Inc.
$33
Azurity Pharmaceuticals, Inc.
$32
PharmaEssentia USA Corporation
$30
EISAI INC.
$27
Pharmacyclics LLC, an AbbVie Company
$25
Spectrum Pharmaceuticals Inc.
$21
Tempus AI, Inc
$20
Coherus Biosciences Inc.
$19
Kite Pharma, Inc.
$17
SOBI, INC
$17
Sumitomo Pharma America, Inc.
$17
MorphoSys, US Inc.
$16
AbbVie Inc.
$16
Lilly USA, LLC
$15
Blueprint Medicines Corporation
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Taiho Oncology, Inc.
$14
CTI BioPharma Corp.
$13
Merck Sharp & Dohme Corporation
$12
Global Blood Therapeutics, Inc.
$12
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · Alecensa · BESREMI · BOSULIF · BRILINTA · BRUKINSA · CABOMETYX · Cabometyx · Columvi · Doptelet · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FOUNDATIONONE · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · Stivarga · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · Vanflyta · Vectibix · Venclexta · Vonjo · WELIREG · XALKORI · XTANDI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
18,432
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bondili is a mixed practice specialist, with above-average Medicare volume (top 4% in NJ).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bondili experienced with epoetin alfa injection (retacrit) for anemia?
Based on Medicare claims data, Dr. Bondili performed 3,820 epoetin alfa injection (retacrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bondili receive payments from pharmaceutical companies?
Yes. Dr. Bondili received a total of $6,709 from 62 companies across 338 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bondili's costs compare to other student in an organized health care education/training programs in Edison?
Dr. Bondili's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bondili) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Edison
Browse student in an organized health care education/training programs in Edison ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in NJ
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in NJ
Which NJ student in an organized health care education/training programs receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology